Literature DB >> 25680286

Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.

Carlos Romá-Mateo1, Carmen Aguado2, José Luis García-Giménez3, Erwin Knecht2, Pascual Sanz4, Federico V Pallardó5.   

Abstract

Lafora disease (LD; OMIM 254780, ORPHA501) is a devastating neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies and caused, in most cases, by mutations in either the EPM2A or the EPM2B gene, encoding respectively laforin, a phosphatase with dual specificity that is involved in the dephosphorylation of glycogen, and malin, an E3-ubiquitin ligase involved in the polyubiquitination of proteins related to glycogen metabolism. Thus, it has been reported that laforin and malin form a functional complex that acts as a key regulator of glycogen metabolism and that also plays a crucial role in protein homeostasis (proteostasis). Regarding this last function, it has been shown that cells are more sensitive to ER stress and show defects in proteasome and autophagy activities in the absence of a functional laforin-malin complex. More recently, we have demonstrated that oxidative stress accompanies these proteostasis defects and that various LD models show an increase in reactive oxygen species and oxidative stress products together with a dysregulated antioxidant enzyme expression and activity. In this review we discuss possible connections between the multiple defects in protein homeostasis present in LD and oxidative stress.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Free radicals; Lafora disease; Laforin; Malin; Oxidative stress; Proteostasis

Mesh:

Substances:

Year:  2015        PMID: 25680286     DOI: 10.1016/j.freeradbiomed.2015.01.034

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  11 in total

1.  Lafora Disease Is an Inherited Metabolic Cardiomyopathy.

Authors:  María Villalba-Orero; Gentzane Sánchez-Elexpuru; Marina López-Olañeta; Oscar Campuzano; Elisabet Bello-Arroyo; Pablo García-Pavía; José M Serratosa; Ramón Brugada; Marina P Sánchez; Enrique Lara-Pezzi
Journal:  J Am Coll Cardiol       Date:  2017-06-20       Impact factor: 24.094

2.  Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.

Authors:  Belén Mollá; Miguel Heredia; Pascual Sanz
Journal:  Mol Neurobiol       Date:  2021-01-14       Impact factor: 5.590

Review 3.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Trehalose Treatment in Zebrafish Model of Lafora Disease.

Authors:  Stefania Della Vecchia; Asahi Ogi; Rosario Licitra; Francesca Abramo; Gabriele Nardi; Serena Mero; Silvia Landi; Roberta Battini; Federico Sicca; Gian Michele Ratto; Filippo Maria Santorelli; Maria Marchese
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

5.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

6.  Degradation of altered mitochondria by autophagy is impaired in Lafora disease.

Authors:  Marcos Lahuerta; Carmen Aguado; Pablo Sánchez-Martín; Pascual Sanz; Erwin Knecht
Journal:  FEBS J       Date:  2018-04-23       Impact factor: 5.542

7.  Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.

Authors:  Irene López-González; Rosa Viana; Pascual Sanz; Isidre Ferrer
Journal:  Mol Neurobiol       Date:  2016-04-04       Impact factor: 5.590

Review 8.  Functional Nutrients for Epilepsy.

Authors:  Ji-Eun Kim; Kyung-Ok Cho
Journal:  Nutrients       Date:  2019-06-10       Impact factor: 5.717

Review 9.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

10.  ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line.

Authors:  Kensuke Nishi; Yuri Iwaihara; Toshiyuki Tsunoda; Keiko Doi; Toshifumi Sakata; Senji Shirasawa; Shuhei Ishikura
Journal:  Cell Death Dis       Date:  2017-12-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.